| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Efficacy of intravenous continuous infusion of fluorouracil compared with bolus administration in advanced colorectal cancer.
|
J Clin Oncol
|
1998
|
3.79
|
|
2
|
Toxicity of fluorouracil in patients with advanced colorectal cancer: effect of administration schedule and prognostic factors.
|
J Clin Oncol
|
1998
|
2.05
|
|
3
|
Correlation of toxicity with pharmacokinetics of pegylated liposomal doxorubicin (Doxil) in metastatic breast carcinoma.
|
Cancer
|
2000
|
1.51
|
|
4
|
[Solitary metastatic involvement of the spleen in squamous cell carcinoma of the cervix].
|
Harefuah
|
1977
|
0.89
|
|
5
|
The management of pericardial effusion in cancer patients.
|
Chest
|
1977
|
0.88
|
|
6
|
The effect of tamoxifen on the endometrium.
|
Breast Cancer Res Treat
|
1993
|
0.88
|
|
7
|
Fetal hemoglobin screening in whole blood and in plasma of cancer patients.
|
Tumour Biol
|
1991
|
0.86
|
|
8
|
Metastatic bone involvement in gynecological malignancies.
|
Radiol Clin (Basel)
|
1978
|
0.83
|
|
9
|
Spontaneous pneumothorax complicating lung metastases from carcinoma of the breast.
|
Radiol Clin (Basel)
|
1977
|
0.83
|
|
10
|
Evaluation of fetal hemoglobin in various malignancies with reference to the patients' age.
|
Tumour Biol
|
1988
|
0.81
|
|
11
|
Radiation therapy for locally advanced breast cancer: prognostic factors and complication rate.
|
Eur J Surg Oncol
|
1990
|
0.78
|
|
12
|
Combined modality treatment for stage III ovarian carcinoma.
|
Radiother Oncol
|
1985
|
0.77
|
|
13
|
The effect of postoperative radiotherapy on the feasibility of optimal dose adjuvant CMF chemotherapy in stage II breast carcinoma.
|
Int J Radiat Oncol Biol Phys
|
1983
|
0.77
|
|
14
|
High-dose metoclopramide and dexamethasone as an antiemetic in outpatients receiving chemotherapy for breast cancer. Second study.
|
Oncology
|
1987
|
0.75
|
|
15
|
Chlorpromazine and dexamethasone versus high-dose metoclopramide and dexamethasone in patients receiving cancer chemotherapy, particularly cis-platinum: a prospective randomized crossover study.
|
Oncology
|
1989
|
0.75
|
|
16
|
Comparison of the response to PHA and suppressor macrophage function in different age groups of cancer patients and healthy controls.
|
Cancer
|
1981
|
0.75
|
|
17
|
Procarbazine, CCNU and vincristine (PCV) combination chemotherapy for brain tumors.
|
Oncology
|
1984
|
0.75
|
|
18
|
Treatment of locally advanced breast carcinoma with high-dose external beam supervoltage radiotherapy.
|
Isr J Med Sci
|
1982
|
0.75
|
|
19
|
Combination chemotherapy in metastatic tumors of unknown origin. 5-Fluorouracil, adriamycin and mitomycin C for adenocarcinomas and adriamycin, vinblastine and mitomycin C for anaplastic carcinomas.
|
Isr J Med Sci
|
1989
|
0.75
|
|
20
|
Acute fatal hypercalcemia complicating therapeutic surgical oophorectomy in breast cancer.
|
Int Surg
|
1977
|
0.75
|
|
21
|
Methylprednisolone and chlorpromazine in patients receiving cancer chemotherapy: a prospective non-randomized study.
|
J Chemother
|
1989
|
0.75
|
|
22
|
[Spontaneous pneumothorax complicating neoplastic diseases].
|
Harefuah
|
1976
|
0.75
|
|
23
|
Response to chemotherapy of breast carcinoma bone metastases: assessment by bone scan.
|
Diagn Imaging
|
1979
|
0.75
|
|
24
|
[Treatment of metastatic breast cancer with aminoglutethimide after failure of tamoxifen].
|
Harefuah
|
1984
|
0.75
|
|
25
|
[Combined chemotherapy in metastatic breast cancer: predictive value of dose levels and performance status].
|
Harefuah
|
1986
|
0.75
|
|
26
|
A preliminary report of a pilot randomized trial comparing cyclophosphamide, methotrexate and 5-fluorouracil with cyclophosphamide, mitoxantrone and 5-fluorouracil in the adjuvant therapy of stage II breast cancer with four or more positive axillary nodes.
|
Anticancer Drugs
|
1993
|
0.75
|
|
27
|
[Life-threatening gastrointestinal toxicity during 5-fluorouracil therapy].
|
Harefuah
|
1977
|
0.75
|
|
28
|
Functional and morphological alterations following isolated rat stomach irradiation. A model for estimation of radiation injury.
|
In Vivo
|
1992
|
0.75
|
|
29
|
Prognostic factors affecting treatment results with combination chemotherapy in metastatic breast cancer.
|
Anticancer Res
|
1986
|
0.75
|
|
30
|
Solitary lung involvement from clear cell carcinoma of the endometrium.
|
Int Surg
|
1978
|
0.75
|
|
31
|
Levels of fibrinogen/fibrin degradation fragment E and related substances in sera and effusions of patients with malignant disease.
|
J Cancer Res Clin Oncol
|
1983
|
0.75
|
|
32
|
Treatment of metastatic breast cancer with aminoglutethimide after progression on chemotherapy and/or hormonal therapy with tamoxifen.
|
Eur J Surg Oncol
|
1985
|
0.75
|
|
33
|
Cyclic combination chemotherapy for metastatic breast cancer: comparison of two CMF schedules.
|
Oncology
|
1981
|
0.75
|
|
34
|
Immune complex-like materials in sera of patients with breast cancer: detection by complement-consumption assay.
|
Isr J Med Sci
|
1982
|
0.75
|
|
35
|
Adverse reaction to 99Tcm sulfur colloid in a routine examination. A case report.
|
Radiol Clin (Basel)
|
1977
|
0.75
|
|
36
|
[Adriamycin in the treatment of primary carcinoma of the liver].
|
Harefuah
|
1976
|
0.75
|
|
37
|
Cyclic combination chemotherapy for metastatic breast cancer.
|
Isr J Med Sci
|
1977
|
0.75
|
|
38
|
CMF (cyclophosphamide, methotrexate, 5-fluorouracil) versus cnf (cyclophosphamide, mitoxantrone, 5-fluorouracil) as adjuvant chemotherapy for stage II lymph-node positive breast cancer: a phase III randomized multicenter study.
|
Am J Clin Oncol
|
2001
|
0.75
|
|
39
|
Multiple parenchymal liver metastases as the first site of recurrent ovarian carcinoma: a case report and review of the literature.
|
Eur J Gynaecol Oncol
|
1997
|
0.75
|
|
40
|
Aminoglutethimide as second line endocrine therapy in advanced breast cancer.
|
Anticancer Res
|
1987
|
0.75
|
|
41
|
[Bleomycin therapy].
|
Harefuah
|
1974
|
0.75
|
|
42
|
Vinblastine, cyclophosphamide and 5-fluorouracil (VEF) combination chemotherapy for metastatic hypernephroma.
|
Oncology
|
1981
|
0.75
|
|
43
|
First, second and third line chemotherapy programs in metastatic breast carcinoma.
|
Isr J Med Sci
|
1982
|
0.75
|
|
44
|
[Results with new cytotoxic agents].
|
Harefuah
|
1976
|
0.75
|